Stephen Ma
Finanzdirektor/CFO bei SCILEX HOLDING COMPANY
Vermögen: 12 175 $ am 30.04.2024
Profil
Stephen Ma is currently working as the Secretary, Chief Financial Officer & Senior VP at Scilex Holding Co. He previously worked as the Director-Finance & Operations at Anwita Biosciences, Inc. Mr. Ma has an undergraduate and graduate degree from San Jose State University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
SCILEX HOLDING COMPANY
0,01% | 17.05.2024 | 14 140 ( 0,01% ) | 12 175 $ | 30.04.2024 |
Aktive Positionen von Stephen Ma
Unternehmen | Position | Beginn |
---|---|---|
SCILEX HOLDING COMPANY | Finanzdirektor/CFO | 22.09.2023 |
Ehemalige bekannte Positionen von Stephen Ma
Unternehmen | Position | Ende |
---|---|---|
Anwita Biosciences, Inc.
Anwita Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Anwita Biosciences, Inc. is a clinical stage biopharmaceutical company located in the US. Anwita's lead product, exenokine-21, has been accepted by China NMPA and the US FDA to initiate clinical studies. The American company specializes in the discovery and development of optimized immunotherapeutics for cancer and autoimmune diseases. Anwita's core technology integrates structure-guided accukine cytokine evolution and accubody discovery of full spectrum nanobodies and antibodies, enabling the development of fully optimized cytokine fusions with superior therapeutic potential, favorable safety profile, and great development ability. The private company's unique product portfolio includes half-live extended exenokines, immune cell- or tumor cell-targeting mableukines, and bi-functional duoleukins. The company is also developing other cytokine-based therapeutics and antibody drug conjugates for the potential treatment of various cancers. | Finanzdirektor/CFO | 01.01.2022 |
Ausbildung von Stephen Ma
San Jose State University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SCILEX HOLDING COMPANY | Health Technology |
Private Unternehmen | 1 |
---|---|
Anwita Biosciences, Inc.
Anwita Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Anwita Biosciences, Inc. is a clinical stage biopharmaceutical company located in the US. Anwita's lead product, exenokine-21, has been accepted by China NMPA and the US FDA to initiate clinical studies. The American company specializes in the discovery and development of optimized immunotherapeutics for cancer and autoimmune diseases. Anwita's core technology integrates structure-guided accukine cytokine evolution and accubody discovery of full spectrum nanobodies and antibodies, enabling the development of fully optimized cytokine fusions with superior therapeutic potential, favorable safety profile, and great development ability. The private company's unique product portfolio includes half-live extended exenokines, immune cell- or tumor cell-targeting mableukines, and bi-functional duoleukins. The company is also developing other cytokine-based therapeutics and antibody drug conjugates for the potential treatment of various cancers. | Health Technology |